3D Medicines Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	68.48	444.32	666.47	696.74	774.31	414.26
Short-Term Investments	206.94	227.15	120.78	136.68	-	-
Trading Asset Securities	171.69	169.52	209.33	108.6	50.18	-
Cash & Short-Term Investments	447.1	840.98	996.58	942.03	824.48	414.26
Cash Growth	-50.24%	-15.61%	5.79%	14.26%	99.02%	-
Accounts Receivable	95.62	47.86	5.46	78.04	65	0.2
Other Receivables	0.08	75.54	79.54	76.63	7.29	10.4
Receivables	97.03	127.09	85	155.91	72.29	10.6
Inventory	1.36	4.06	4.61	1.2	0.01	-
Restricted Cash	168.22	-	-	-	0.07	-
Other Current Assets	88.89	15.62	8.97	43.93	22.37	36.9
Total Current Assets	802.6	987.75	1,095	1,143	919.23	461.76
Property, Plant & Equipment	140.12	147.73	193.25	177.84	118.54	26.8
Long-Term Investments	45.15	23.34	70.59	-	-	-
Other Intangible Assets	0.58	0.63	0.73	0.83	0.93	-
Other Long-Term Assets	153.53	56.82	11.89	6.02	17.18	7.66
Total Assets	1,142	1,216	1,429	1,332	1,060	496.22
Accounts Payable	52.56	51.13	71.9	15.88	3.74	2.42
Accrued Expenses	-	164.3	124.35	183.83	111.18	81.54
Short-Term Debt	-	195.59	174.37	103.99	-	3.52
Current Portion of Long-Term Debt	148.83	9	27	-	3,094	215.24
Current Portion of Leases	9.12	8.27	23.23	11.31	12.75	3.79
Current Income Taxes Payable	-	1.8	1.91	-	1.43	0.64
Current Unearned Revenue	-	-	24.54	-	-	-
Other Current Liabilities	294.38	57.69	53.08	61.24	24.98	7.86
Total Current Liabilities	504.89	487.79	500.37	376.25	3,248	315.01
Long-Term Debt	-	16.5	29.24	27	38.82	1,430
Long-Term Leases	5.02	8.25	28.58	33.4	45.99	13.06
Long-Term Unearned Revenue	-	-	-	-	-	7.58
Total Liabilities	509.91	512.54	558.2	436.65	3,333	1,766
Common Stock	0.23	0.23	0.23	0.22	0.06	0.04
Additional Paid-In Capital	-	4,785	4,785	4,228	134.66	-
Retained Earnings	-	-4,343	-4,161	-3,636	-2,612	-1,270
Treasury Stock	-0.01	-0.17	-0.01	-0.03	-0.03	-
Comprehensive Income & Other	715.93	343.22	311.97	350.98	239.02	-
Total Common Equity	716.15	785.06	936.74	943	-2,238	-1,270
Minority Interest	-84.08	-81.35	-66.05	-47.59	-34.55	-
Shareholders' Equity	632.07	703.71	870.69	895.41	-2,273	-1,270
Total Liabilities & Equity	1,142	1,216	1,429	1,332	1,060	496.22
Total Debt	162.98	237.62	282.43	175.7	3,192	1,666
Net Cash (Debt)	284.13	603.36	714.15	766.33	-2,367	-1,252
Net Cash Growth	-55.51%	-15.51%	-6.81%	-	-	-
Net Cash Per Share	1.16	2.46	3.13	16.85	-60.61	-27.45
Filing Date Shares Outstanding	245.09	244.97	245.07	224.2	36.45	45.6
Total Common Shares Outstanding	245.09	244.97	245.07	224.2	36.45	45.6
Working Capital	297.71	499.96	594.78	766.81	-2,329	146.75
Book Value Per Share	2.92	3.20	3.82	4.21	-61.40	-27.85
Tangible Book Value	715.57	784.44	936.01	942.17	-2,239	-1,270
Tangible Book Value Per Share	2.92	3.20	3.82	4.20	-61.43	-27.85
Machinery	-	9.58	8.28	8.06	7.06	3.41
Construction In Progress	-	112.02	112.02	99.87	28.16	-
Leasehold Improvements	-	31.16	35.09	33.16	23.43	10.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.